RE:Inside CBDTAnd that's the recap from Yahoo finance:
1. Steve McAuley is thee only small market-cap CEO with SixSigma certification.
2. Steve has set up this company perfectly in the short-term, long-term and the transition from the former to the latter.
3. The newly acquired Kai Labs has its own non-invasive saliva test. It has FDA, EUA, MDEL approvals and is the gold standard in PCR quality Covid Testing.
4. CBDT is in ongoing discussions to supply COVID testing to Airports, airlines, cruise lines, Caribbean nations, MLB and sports venues and teams. They’ve already established contracts in the film industry and with Dallas Market Center.
Steve has stated that we can see 1000-2000 tests being done daily come the end of Q1.
1000 x $150 x 30 = 4.5M revenue MONTHLY in testing.
5. Their clinic acquisitions(the long-term sustainable play) and partnership gives CBDT a clear path to 100M in annually revenue.
6. The company is also debt free. Steve has also stated that companies in a smilies healthcare space can run 25x-35x market caps based on annual revenues.
7. Let’s not forget about potential revenues in the future from the companies psilocybin and psychedelics division.
Conclusion:
This company is a gold mine.
It has a short-term, a long-term plan and a plan to seamlessly transition revenue sustainably (if your worried about revenues after covid). It has a plan to grow exponentially for years to come with a unbelievable CEO and leadership team that has stated that he believes CBDT can rival some of the biggest healthcare companies in North America.
*The company is debt free.*